Nautilus Biotechnology, Inc. (NAUT)
2.97
+0.02
(+0.68%)
USD |
NASDAQ |
Apr 13, 16:00
3.03
+0.06
(+2.02%)
After-Hours: 20:00
Nautilus Biotechnology EPS Diluted (Quarterly) : -0.109 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0758 |
| Niagen Bioscience, Inc. | 0.0489 |
| Cytek Biosciences, Inc. | -0.3439 |
| Pyxis Oncology, Inc. | -0.2888 |
| HeartSciences, Inc. | -0.6278 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.78M |
| Total Expenses (Quarterly) | 13.78M |
| Enterprise Value | 302.51M |
| Earnings Yield | -15.73% |
| Normalized Earnings Yield | -15.73 |